Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas

Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study analyzed the efficacy and toxicity of temozolomide in 25 adult patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Seung-Ho, Kim, Moon-Kyu, Lee, Tae-Kyu, Lee, Kwan-Sung, Jeun, Sin-Soo, Park, Chun-Kun, Kang, Joon-Ki, Kim, Moon-Chan, Hong, Yong-Kil
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2006
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729901/
https://ncbi.nlm.nih.gov/pubmed/16891823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2006.21.4.739
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars